Cancer Center at Beth Israel Deaconess Medical Center is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Cancer Center at Beth Israel Deaconess Medical Center has participated in 1 clinical trials.
Therapeutic areas: Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Dose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma.
Sponsors: ModernaTX, Inc..
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cancer Center at Beth Israel Deaconess Medical Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cancer Center at Beth Israel Deaconess Medical Center has 1 clinical trials on record. Their work covers Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Dose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma.
Cancer Center at Beth Israel Deaconess Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.